Bioprocess Validation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Bioprocess Validation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : May, 2020 | Pharmaceutical | PPT format

Report Digest


Global Bioprocess Validation Market: Overview

Rigorous safety and quality laws thatcontrol the entire process of product certification and testing acrosspharmaceutical and biopharmaceutical industries are prognosticated to spell growth forglobal bioprocess validation market over the timeframe of stipulation.

In addition to that, numerous regulatory mandates in the healthcare sector, coupled with increasing trend of outsourcing the services of bioprocess validation, are expected to stimulate growth for the global bioprocess validation market. Services in the healthcare sector need to be in line with Good Manufacturing Practices (GMPs), which is setting the standard for the healthcare industry, thereby driving the market growth.

Global bioprocess validation market is segmented on the basis of test type, process component, end-user, and region.

Global Bioprocess Validation Market: Notable Developments

The below-mentioned strategic moves in the global bioprocess validationmarket reveal the key aspects of the dynamic:

  • In 2018, Meissner Filtration Products made an announcement that it has completed the process of acquisition of PDC Aseptic Filling Systems. The latter suppliessealers and advanced aseptic filling systems to the pharmaceutical sector. Following the acquisition, it is expected that the products of PDC Aseptic Filling Systems would complement Meissner’spresent portfolio of process solutions. These comprise unit processing offerings, single-use systems fluid handling, and filtration.
  • In 2019, Thermo Fisher Scientific Inc., a leading developer of biotechnology product, and Brammer Bio, famed maker of viral vectorfor cell and gene therapies, entered into a definitive agreement. Honoring the agreement, Thermo Fisher made an acquisition ofBrammer Bio.

Some of the most prominent competitors operating in the competitive landscape of global bioprocess validation market include –

  • Filtration Products Inc.
  • Thermo Fisher Scientific Inc.
  • Sartorius Stedim Biotech
  • Cobetter Filtration Equipments Co., Ltd.
  • Eurofins Scientific

Global Bioprocess Validation Market: Growth Drivers

Stringent Safety Measures for Product Certification Accelerates Growth

Global bioprocess validation market is expected to be fuelled by the strict quality and safety rules that govern product testing and certification process across the pharmaceutical and biopharmaceutical sectors. The World Health Organization (WHO) asserts that quality management in the drug industry is an essential element, and validation is an essential part of GMP. According to the WHO, licensed pharmaceutical products must always be made strictly by the licensed manufacturers only. The agencyfurther mandates that the activities of those manufacturers need to be regularly scrutinized from time to time by competent nationalauthorities.

Furthermore, increased expenditure on research and development activities in the area of life sciences together with the rising demand for outsourcing the services of bioprocess validation are likely to propel the global bioprocess validation market towards growth.

Global Bioprocess Validation Market: Regional Outlook

Considering geographies of the global bioprocess validation market, North America is likely to hold lion’s share throughout the assessment period of 2018 – 2028. Europe is likely to trail North America in the coming years.

The North America bioprocess validation market is likely to gain traction fromthe concentration of a large number of key service providers of bioprocess validation in the region. In addition to that, strict regulations pertaining to the production of biopharmaceutical products are adding impetus to the demand for bioprocess validation systems in the region.

Asia Pacific is expected to emerge as a rapidly expanding region in the global bioprocess validation market during the period of assessment. This can be attributed primarily to the expanding capacities of numerous biopharmaceutical manufacturers and increased spending on research and development activities in life sciencesin the region.

The global bioprocess validation market is segmented as:

Test Type

  • Extractables and Leachables
  • Integrity Testing
  • Microbiology Testing

Process Component

  • Filter Element
  • Bioreactors

End-User

  • CDMO
  • Biotechnology Companies
  • Pharmaceutical Companies

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.

Wish to check Table of Contents of this report?

Click below to Request TOC

Request TOC